OPK - OPKO Health Inc Stock Price, Fair Value and News

1.48USD+0.06 (+4.23%)Market Closed

Market Summary

USD1.48+0.06

Market Closed

4.23%

OPK Stock Price

View Fullscreen

OPK RSI Chart

OPK Valuation

Market Cap

1.0B

Price/Earnings (Trailing)

-4.09

Price/Sales (Trailing)

1.29

EV/EBITDA

-7.49

Price/Free Cashflow

-25.09

OPK Price/Sales (Trailing)

OPK Profitability

EBT Margin

-31.33%

Return on Equity

-20.15%

Return on Assets

-12.79%

Free Cashflow Yield

-3.99%

OPK Fundamentals

OPK Revenue

Revenue (TTM)

799.6M

Rev. Growth (Yr)

-26.89%

Rev. Growth (Qtr)

-4.52%

OPK Earnings

Earnings (TTM)

-252.4M

Earnings Growth (Yr)

-348%

Earnings Growth (Qtr)

-23.09%

Breaking Down OPK Revenue

Last 7 days

-0.7%

Last 30 days

15.6%

Last 90 days

17.5%

Trailing 12 Months

-16.8%

How does OPK drawdown profile look like?

OPK Financial Health

Current Ratio

1.91

Debt/Equity

Debt/Cashflow

-10.19

OPK Investor Care

Buy Backs (1Y)

9.79%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	799.6M	0	0	0
2023	912.6M	868.1M	866.9M	863.5M
2022	1.6B	1.4B	1.2B	1.0B
2021	1.8B	1.9B	1.9B	1.8B
2020	891.0M	965.8M	1.2B	1.4B
2019	957.8M	920.5M	899.4M	901.9M
2018	954.5M	925.6M	929.4M	990.3M
2017	1.1B	1.1B	1.1B	966.0M
2016	730.6M	1.0B	1.1B	1.1B
2015	98.9M	117.8M	241.1M	491.7M
2014	87.4M	87.2M	86.3M	91.1M
2013	69.6M	83.3M	92.1M	96.5M
2012	29.8M	31.6M	36.6M	47.0M
2011	32.3M	33.3M	34.4M	28.0M
2010	0	12.4M	20.5M	28.5M
2009	0	0	0	4.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

CEO	Dr. Phillip Frost Ph.D.
WEBSITE	opko.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	4196

OPKO Health Inc Frequently Asked Questions

What is the ticker symbol for OPKO Health Inc? What does OPK stand for in stocks?

OPK is the stock ticker symbol of OPKO Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of OPKO Health Inc (OPK)?

As of Fri Jul 26 2024, market cap of OPKO Health Inc is 1.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OPK stock?

You can check OPK's fair value in chart for subscribers.

Is OPKO Health Inc a good stock to buy?

The fair value guage provides a quick view whether OPK is over valued or under valued. Whether OPKO Health Inc is cheap or expensive depends on the assumptions which impact OPKO Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OPK.

What is OPKO Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, OPK's PE ratio (Price to Earnings) is -4.09 and Price to Sales (PS) ratio is 1.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OPK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on OPKO Health Inc's stock?

In the past 10 years, OPKO Health Inc has provided -0.166 (multiply by 100 for percentage) rate of return.